Board of Directors

Noreen Griffin

Founder, Chief Executive Officer, and Director

Ms. Griffin is one of the founders of Cytocom Inc and Immune Therapeutics and is its chief executive officer (CEO). Ms. Griffin was a vital part of the acquisition of the patents and therapies involving MENK and LDN and was involved with the inventors and patent holders for over five years before joining the team that formed what is now Immune Therapeutics. Ms. Griffin has over 25 years of industry experience, having founded and led a number of startup companies. She has played an integral role in raising multiple rounds of private and venture capital funds on behalf of clients. Ms. Griffin has owned and operated a small consulting firm located in Washington, D.C. and Florida. She has also served as CEO and vice president of a number of small public companies over the last 10 years. In addition, Ms. Griffin has experience in the administration of companies in bankruptcies. From 1998 to 2012, she was the sole officer and director of Supertrail Manufacturing Co., Inc., a private company in Aberdeen, Mississippi. From 1997 to 1999, she was chief financial officer of Environmental Remediation Holdings, Inc., a public reporting company in Lafayette, Louisiana. From 2004 to 2009, she was an advisor to Global Environmental Energy Corp., a public company, and assumed the role of sole officer for the purpose of the company’s bankruptcy. From 2007 to 2012, Ms. Griffin was CEO of pH Solutions, a private company in Boston, Massachusetts. Since 2010, she has been a partner of Griffin Enterprises Group, a firm providing chief financial officer services to its clients on a part-time basis.

Christopher Pearce

Founder and Director

Mr. Pearce was born in the United Kingdom and educated at Lord Wandsworth College and London University, where he received a LLB (Bachelor of Law). He accepted a position with Immune Therapeutics in late 2011, due to his 10-year history and involvement with Dr. Nicholas Plotnikoff. In addition to his position with Immune Therapeutics, he is one of the founding principles of pH Pharmaceutical, Inc. (a pharmaceutical company focused on the commercial application and licensing of a patented technology) and its affiliated company, pH Solutions, since its inception in December 2007. Mr. Pearce has had an association with independent filmmakers for over 30 years. He was head of Cannon Group production and served as chairman and CEO from 1991 to 1994. Over the years as director, COO, and CEO at Cannon Group, Mr. Pearce managed more than 5,000 employees worldwide and $500 million in revenue per year. His responsibilities included running large operations that required sourcing products and services, contract negotiation, marketing and advertising, scheduling, warehousing and inventory management, and employee oversight. When he left Cannon Group in 1994, he began working for Global Pictures, Inc. Mr. Pearce retired from filmmaking in 2000 and has since worked as an advisor on numerous projects.